141 related articles for article (PubMed ID: 19846043)
1. Polaprezinc, a zinc compound, is distributed to the lingual epithelium and increases its zinc concentration in zinc-deficient rats.
Hamano H; Yoshinaga K; Tanaka T; Eta R; Horii T; Kawabata Y; Furuta S; Takei M
Life Sci; 2009 Nov; 85(21-22):759-64. PubMed ID: 19846043
[TBL] [Abstract][Full Text] [Related]
2. Effects of polaprezinc on morphological change of the tongue in zinc-deficient rats.
Kinomoto T; Sawada M; Ohnishi Y; Yamaguchi T; Tsuge S; Ogawa S; Washizuka M; Minaguchi J; Mera Y; Takehana K
J Oral Pathol Med; 2010 Sep; 39(8):617-23. PubMed ID: 21054547
[TBL] [Abstract][Full Text] [Related]
3. Effect of polaprezinc on taste disorders in zinc-deficient rats.
Hamano H; Yoshinaga K; Eta R; Emori Y; Kawasaki D; Iino Y; Sawada M; Kuroda H; Takei M
Biofactors; 2006; 28(3-4):185-93. PubMed ID: 17473379
[TBL] [Abstract][Full Text] [Related]
4. [Development of polaprezinc research].
Takei M
Yakugaku Zasshi; 2012; 132(3):271-7. PubMed ID: 22382829
[TBL] [Abstract][Full Text] [Related]
5. Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats.
Kono T; Asama T; Chisato N; Ebisawa Y; Okayama T; Imai K; Karasaki H; Furukawa H; Yoneda M
Life Sci; 2012 Jan; 90(3-4):122-30. PubMed ID: 22100444
[TBL] [Abstract][Full Text] [Related]
6. Preventive effect of zinc compounds, polaprezinc and zinc acetate against the onset of hepatitis in Long-Evans Cinnamon rat.
Sugawara N; Katakura M; Sugawara C
Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):167-76. PubMed ID: 10461683
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data.
Furihata K; Tsuchikawa M; Miwa T; Naito Y; Oba K; Sakagami M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316581
[TBL] [Abstract][Full Text] [Related]
8. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites.
Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T
Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862
[TBL] [Abstract][Full Text] [Related]
9. Disposition of polaprezinc (zinc L-carnosine complex) in rat gastrointestinal tract and effect of cimetidine on its adhesion to gastric tissues.
Furuta S; Toyama S; Miwa M; Sano H
J Pharm Pharmacol; 1995 Aug; 47(8):632-6. PubMed ID: 8583362
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution of polaprezinc in rats determined by the double tracer method.
Furuta S; Suzuki M; Toyama S; Miwa M; Sano H
J Pharm Biomed Anal; 1999 Mar; 19(3-4):453-61. PubMed ID: 10704111
[TBL] [Abstract][Full Text] [Related]
11. Oral treatment of pressure ulcers with polaprezinc (zinc L-carnosine complex): 8-week open-label trial.
Sakae K; Yanagisawa H
Biol Trace Elem Res; 2014 Jun; 158(3):280-8. PubMed ID: 24691900
[TBL] [Abstract][Full Text] [Related]
12. Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study.
Sakae K; Suka M; Yanagisawa H
J Clin Psychopharmacol; 2020; 40(6):599-606. PubMed ID: 33044355
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the cellular actions of polaprezinc (zinc-L-carnosine) and ZnCl2.
Seo H; Ogata-Ikeda I; Ishida S; Okano Y; Oyama Y
Life Sci; 2012 Jun; 90(25-26):1015-9. PubMed ID: 22683432
[TBL] [Abstract][Full Text] [Related]
14. Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients.
Fukushima T; Horike H; Fujiki S; Kitada S; Sasaki T; Kashihara N
Ther Apher Dial; 2009 Jun; 13(3):213-9. PubMed ID: 19527468
[TBL] [Abstract][Full Text] [Related]
15. Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity.
Tsutsumi K; Kaname T; Shiraishi H; Kawashiri T; Egashira N
J Pharmacol Sci; 2016 Jun; 131(2):146-9. PubMed ID: 27262900
[TBL] [Abstract][Full Text] [Related]
16. [The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy].
Mizukami Y; Sato J; Nihei S; Kashiwaba M; Kudo K; Okuyama H; Tamura K
Gan To Kagaku Ryoho; 2016 Aug; 43(8):979-83. PubMed ID: 27539040
[TBL] [Abstract][Full Text] [Related]
17. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc.
Nishiwaki H; Kato S; Sugamoto S; Umeda M; Morita H; Yoneta T; Takeuchi K
J Physiol Pharmacol; 1999 Jun; 50(2):183-95. PubMed ID: 10424716
[TBL] [Abstract][Full Text] [Related]
18. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
[TBL] [Abstract][Full Text] [Related]
19. Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate.
Kato S; Nishiwaki H; Konaka A; Takeuchi K
Dig Dis Sci; 1997 Oct; 42(10):2156-63. PubMed ID: 9365151
[TBL] [Abstract][Full Text] [Related]
20. Absorption mechanism of polaprezinc (zinc L-carnosine complex) by an everted sac method.
Furuta S; Toyama S; Sano H
Xenobiotica; 1994 Nov; 24(11):1085-94. PubMed ID: 7701850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
